Industry Pipeline - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Industry Pipeline
Interphex Showcase 2010.

Pharmaceutical Technology
Volume 34, Issue 4, pp. 128-135



Powder filling
Capsugel's Xcelodose S system offers automated, programmable, and precise metering of drug powder into capsules or other containers by weight. The unit allows companies to fill capsules with drug substances alone, thereby eliminating the need for excipient compatibility and preformulation activities. The device weighs doses as low as 100 μg and greater than 100 mg with an accuracy of < 2%. Capsugel, Greenwood, SC http://www.capsugel.com/ tel. 800.845.6973



Tablet press
Specialty Measurement offers the MiniTab press, which is designed to manufacture tablets ranging from 0.5 to 4 mm in diameter. The introduction model can produce < 300,000 tablets/h; larger models will be capable of making > 2 million tablets/h. The compact size of the machine, less than 250 500 500 mm, makes it ideal for glove-box applications. SMI, Lebanon, NJ http://www.smitmc.com/ tel. 908.534.1546



Single-use solutions
The FlexAct system focuses on biomanufacturing unit operations and can be used with preconfigured single-use equipment for upstream and downstream processing steps. The system allows users of stainless-steel equipment or individual disposable components to convert to single-use unit operations. Sartorius Stedim Biotech, Bohemia, NY http://www.sartorius-stedim.com/ tel. 800.368.7178



Weldable tubing
PureWeld weldable thermoplastic elastomer (TPE) tubing is suitable for biopharmaceutical processes from research to production. The product is designed to produce a quick, secure, and connector-free fluid path. The TPE contains no animal-derived material that could leach into products. Each piece of tubing displays its lot number and expiration date. Watson-Marlow, Wilmington, MA http://www.watson-marlow.com/ tel. 800.282.8823


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
35%
Breakthrough designations
12%
Protecting the supply chain
35%
Expedited reviews of drug submissions
12%
More stakeholder involvement
6%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
USP Faces New Challenges
Source: Pharmaceutical Technology,
Click here